High Tower Advisors, LLC Pacira Bio Sciences, Inc. Transaction History

High Tower Advisors, LLC

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$25.5 - $31.51 $2,805 - $3,466	110 Added 0.76%	14,621 $418,000
Q1 2024 May 06, 2024	BUY	$27.7 - $35.48 $158,305 - $202,768	5,715 Added 64.97%	14,511 $424,000
Q4 2023 Feb 12, 2024	BUY	$26.32 - $34.31 $22,766 - $29,678	865 Added 10.91%	8,796 $296,000
Q3 2023 Nov 08, 2023	BUY	$30.68 - $40.09 $243,323 - $317,953	7,931 New	7,931 $243,000
Q2 2022 Aug 10, 2022	SELL	$51.49 - $81.64 $1.76 Million - $2.79 Million	-34,201 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$60.03 - $76.49 $1.85 Million - $2.36 Million	30,812 Added 909.18%	34,201 $2.6 Million
Q4 2021 Feb 10, 2022	SELL	$47.97 - $62.21 $7,531 - $9,766	-157 Reduced 4.43%	3,389 $203,000
Q3 2021 Nov 12, 2021	BUY	$54.64 - $61.3 $8,906 - $9,991	163 Added 4.82%	3,546 $200,000
Q2 2021 Aug 06, 2021	BUY	$59.18 - $69.99 $532 - $629	9 Added 0.27%	3,383 $203,000
Q4 2020 Feb 10, 2021	SELL	$50.47 - $66.26 $50,470 - $66,260	-1,000 Reduced 22.86%	3,374 $200,000
Q3 2020 Nov 13, 2020	BUY	$51.97 - $63.0 $24,633 - $29,862	474 Added 12.15%	4,374 $260,000
Q2 2020 Aug 10, 2020	BUY	$30.8 - $52.47 $120,120 - $204,633	3,900 New	3,900 $205,000
Q1 2019 May 15, 2019	SELL	$36.47 - $42.17 $201,861 - $233,410	-5,535 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$41.31 - $52.16 $2,809 - $3,546	-68 Reduced 1.21%	5,535 $237,000
Q3 2018 Nov 09, 2018	BUY	$32.85 - $52.0 $184,058 - $291,356	5,603 New	5,603 $274,000
Q1 2018 May 15, 2018	SELL	$29.98 - $46.35 $179,880 - $278,100	-6,000 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$35.7 - $39.5 $214,200 - $237,000	6,000	6,000 $226,000

263

50.4M

429K

391K

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $892M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on High Tower Advisors, LLC with notifications on news.